THE MAGNITUDE OF THE RESPONSE OF HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA TO SORAFENIB IS AFFECTED BY THE EXPRESSION OF INACTIVATING VARIANTS IN THE SLC22A1 GENE

被引：0
|
作者：
Herraez, E. [1 ]
Briz, O. [1 ,2 ]
Lozano, E. [1 ]
Macias, R. I. R. [1 ,2 ]
Robledo, V. S. [1 ]
Hernandez-Iglesias, J. [1 ]
Gonzalez-Hernandez, A. [1 ]
Bujanda, L. [2 ,3 ]
Banales, J. [2 ,3 ]
Marin, J. J. G. [1 ,2 ]
机构：
[1] Univ Salamanca, Lab Expt Hepatol & Drug Targeting HEVEFARM, Biomed Res Inst Salamanca IBSAL, E-37008 Salamanca, Spain
[2] Natl Inst Study Liver & Gastrointestinal Dis CIBE, Barcelona, Spain
[3] Univ Basque Country EHU UPV, Dept Gastroenterol, Donostia Hosp, Inst Biodonostia, San Sebastian, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)61052-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1051
引用
收藏
页码：S431 / S432
页数：2
相关论文
共 24 条
  • [1] Expression of SLC22A1 Variants May Affect the Response of Hepatocellular Carcinoma and Cholangiocarcinoma to Sorafenib
    Herraez, Elisa
    Lozano, Elisa
    Macias, Rocio I. R.
    Vaquero, Javier
    Bujanda, Luis
    Banales, Jesus M.
    Marin, Jose J. G.
    Briz, Oscar
    HEPATOLOGY, 2013, 58 (03) : 1065 - 1073
  • [2] The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
    Ningrum, Vitarani Dwi Ananda
    Sadewa, Ahmad Hamim
    Ikawati, Zullies
    Yuliwulandari, Rika
    Ikhsan, M. Robikhul
    Fajriyah, Rohmatul
    PLOS ONE, 2022, 17 (07):
  • [3] Effectiveness of Metformin in patients with type II diabetes related to variants in the SLC22A1 gene
    Yang, Pablo
    Carlos Nicolas, Juan
    Ariel Galvan, Cristian
    Velez, Pablo
    Da Ronco, Luciano
    Tomas Diaz, Gustavo
    Miguel Beltramo, Dante
    Walter Soria, Nestor
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2014, 48 (02): : 229 - 235
  • [4] ASSOCIATION OF VARIANTS OF SLC22A1 (OCT1) WITH THE RESPONSE TO IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Manuel, Perez-Encinas
    Angueira Francisco, Barros
    Jose, Rabunal Martinez M.
    Redondo Carlos, Ulibarrena
    Varela Nicolas, Diaz
    Garcia Celsa, Quinteiro
    Martinez Teresa, Gonzalez
    Perez Sonia, Gonzalez
    Vence Natalia, Alonso
    Lopez Angeles, Bendana
    Arias Jose, Diaz
    Mendez Isabel, Abuin
    Blanco Aitor, Abuin
    Perez Laura, Bao
    Orgeira Adrian, Mosquera
    Jose Luis, Bello Lopez
    HAEMATOLOGICA, 2016, 101 : 178 - 178
  • [5] Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
    Soto, Meraris
    Reviejo, Maria
    Al-Abdulla, Ruba
    Romero, Marta R.
    Macias, Rocio I. R.
    Boix, Loreto
    Bruix, Jordi
    Serrano, Maria A.
    Marin, Jose J. G.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (05):
  • [6] ABCG2 and SLC22A1 Expression Are Associated with Imatinib Response in Chronic Myeloid Leukemia
    Vivona, Douglas
    Lima, Luciene Terezina
    Bueno, Carolina Tosin
    Hirata, Rosario D. C.
    Hirata, Mario H.
    Luchessi, Andre Ducati
    Zanichelli, Maria
    Chiattone, Carlos S.
    Guerra-Shinohara, Elvira Maria
    BLOOD, 2011, 118 (21) : 618 - 618
  • [7] Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
    Heise, Michael
    Lautem, Anja
    Knapstein, Johanna
    Schattenberg, Joern M.
    Hoppe-Lotichius, Maria
    Foltys, Daniel
    Weiler, Nina
    Zimmermann, Anca
    Schad, Arno
    Gruendemann, Dirk
    Otto, Gerd
    Galle, Peter R.
    Schuchmann, Marcus
    Zimmermann, Tim
    BMC CANCER, 2012, 12
  • [8] DOWNREGULATION OF ORGANIC CATION TRANSPORTERS OCT1 (SLC22A1) AND OCT3 (SLC22A3) IN HUMAN HEPATOCELLULAR CARCINOMA AND THEIR PROGNOSTIC SIGNIFICANCE
    Knapstein, J.
    Heise, M.
    Lautem, A.
    Schattenberg, J.
    Galle, P. R.
    Otto, G.
    Schuchmann, M.
    Zimmermann, T.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S118 - S118
  • [9] Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
    Michael Heise
    Anja Lautem
    Johanna Knapstein
    Jörn M Schattenberg
    Maria Hoppe-Lotichius
    Daniel Foltys
    Nina Weiler
    Anca Zimmermann
    Arno Schad
    Dirk Gründemann
    Gerd Otto
    Peter R Galle
    Marcus Schuchmann
    Tim Zimmermann
    BMC Cancer, 12
  • [10] DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
    Schaeffeler, Elke
    Hellerbrand, Claus
    Nies, Anne T.
    Winter, Stefan
    Kruck, Stephan
    Hofmann, Ute
    van der Kuip, Heiko
    Zanger, Ulrich M.
    Koepsell, Hermann
    Schwab, Matthias
    GENOME MEDICINE, 2011, 3
123